These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24918666)

  • 41. Update on treatment of hereditary angioedema.
    Buyantseva LV; Sardana N; Craig TJ
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):89-98. PubMed ID: 22830287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
    Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
    Zanichelli A; Mansi M; Periti G; Cicardi M
    Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
    Nzeako UC; Longhurst HJ
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.
    Zanichelli A; Azin GM; Cristina F; Vacchini R; Caballero T
    Orphanet J Rare Dis; 2018 Apr; 13(1):51. PubMed ID: 29631595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Icatibant in hereditary angioedema: news and challenges.
    Bouillet L
    Expert Rev Clin Immunol; 2011 May; 7(3):267-72. PubMed ID: 21595592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
    Baş M; Greve J; Hoffmann TK; Reshef A; Aberer W; Maurer M; Kivity S; Farkas H; Floccard B; Arcoleo F; Martin L; Sitkauskiene B; Bouillet L; Schmid-Grendelmeier P; Li H; Zanichelli A
    Allergy; 2013 Nov; 68(11):1452-9. PubMed ID: 24111645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States.
    Tachdjian R; Johnson KE; Casso D; Oliveria SA; Devercelli G; Jain G
    Allergy Asthma Proc; 2020 May; 41(3):172-182. PubMed ID: 32375961
    [No Abstract]   [Full Text] [Related]  

  • 49. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week.
    Bork K; Hardt J
    Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on the acute treatment of hereditary angioedema.
    Riedl MA
    Allergy Asthma Proc; 2011; 32(1):11-6. PubMed ID: 21262093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on therapeutic developments for hereditary angioedema.
    Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.
    Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ
    Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies.
    Wahn V; Aberer W; Eberl W; Faßhauer M; Kühne T; Kurnik K; Magerl M; Meyer-Olson D; Martinez-Saguer I; Späth P; Staubach-Renz P; Kreuz W
    Eur J Pediatr; 2012 Sep; 171(9):1339-48. PubMed ID: 22543566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks.
    Prematta MJ; Bewtra AK; Levy RJ; Wasserman RL; Jacobson KW; Machnig T; Craig TJ
    Adv Ther; 2012 Oct; 29(10):913-22. PubMed ID: 23054691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current drugs in early development for hereditary angioedema: potential for effective treatment.
    Bork K
    Expert Opin Investig Drugs; 2014 Jul; 23(7):887-91. PubMed ID: 24797354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema.
    Aberer W; Maurer M; Reshef A; Longhurst H; Kivity S; Bygum A; Caballero T; Bloom B; Nair N; Malbrán A
    Allergy; 2014 Mar; 69(3):305-14. PubMed ID: 24438203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema.
    Hakl R; Kuklínek P; Sobotková M; Krčmová I; Králíčková P; Vachová M; Hanzlíková J; Nováčková M; Svoboda M; Kováčová I; Litzman J
    Clin Exp Allergy; 2022 Aug; 52(8):994-997. PubMed ID: 35662289
    [No Abstract]   [Full Text] [Related]  

  • 60. C1-esterase inhibitor for short-term prophylaxis in a patient with hereditary angioedema with normal C1 inhibitor function.
    Yu SK; Callum J; Alam A
    J Clin Anesth; 2016 Dec; 35():488-491. PubMed ID: 27871580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.